These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Emerging nicotine delivery products. Implications for public health. Benowitz NL. Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992 [Abstract] [Full Text] [Related]
7. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction. Kozlowski LT, Abrams DB. BMC Public Health; 2016 May 24; 16():432. PubMed ID: 27221096 [Abstract] [Full Text] [Related]
9. Tobacco, nicotine and harm reduction. Le Houezec J, McNeill A, Britton J. Drug Alcohol Rev; 2011 Mar 24; 30(2):119-23. PubMed ID: 21375611 [Abstract] [Full Text] [Related]
10. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. Hatsukami DK, Lemmonds C, Zhang Y, Murphy SE, Le C, Carmella SG, Hecht SS. J Natl Cancer Inst; 2004 Jun 02; 96(11):844-52. PubMed ID: 15173268 [Abstract] [Full Text] [Related]
11. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health. Bates C, Fagerström K, Jarvis MJ, Kunze M, McNeill A, Ramström L. Tob Control; 2003 Dec 02; 12(4):360-7. PubMed ID: 14660767 [Abstract] [Full Text] [Related]
13. Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P, Benowitz NL. Nicotine Tob Res; 2017 Feb 02; 19(2):160-167. PubMed ID: 27613896 [Abstract] [Full Text] [Related]
14. Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers. Cobb CO, Weaver MF, Eissenberg T. Tob Control; 2010 Oct 02; 19(5):367-73. PubMed ID: 19346218 [Abstract] [Full Text] [Related]
15. Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study. Kotlyar M, Hertsgaard LA, Lindgren BR, Jensen JA, Carmella SG, Stepanov I, Murphy SE, Hecht SS, Hatsukami DK. Cancer Epidemiol Biomarkers Prev; 2011 Jan 02; 20(1):91-100. PubMed ID: 21068204 [Abstract] [Full Text] [Related]
16. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study. Pesola F, Phillips-Waller A, Beard E, Shahab L, Sweanor D, Jarvis M, Hajek P. Public Health Res (Southampt); 2023 Sep 02; 11(7):1-39. PubMed ID: 37795840 [Abstract] [Full Text] [Related]
17. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction? Frost-Pineda K, Appleton S, Fisher M, Fox K, Gaworski CL. Nicotine Tob Res; 2010 Nov 02; 12(11):1055-67. PubMed ID: 20847148 [Abstract] [Full Text] [Related]
18. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction. Kozlowski LT. Am J Prev Med; 2007 Dec 02; 33(6 Suppl):S379-86. PubMed ID: 18021913 [Abstract] [Full Text] [Related]
19. Smokeless tobacco: a gateway to smoking or a way away from smoking. Melikian AA, Hoffmann D. Biomarkers; 2009 Jul 02; 14 Suppl 1():85-9. PubMed ID: 19604066 [Abstract] [Full Text] [Related]
20. Snuffing out cigarette sales and the smoking deaths epidemic. Laugesen M. N Z Med J; 2007 Jun 15; 120(1256):U2587. PubMed ID: 17589555 [Abstract] [Full Text] [Related] Page: [Next] [New Search]